Sulat James R's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Mar 16, 2023
- Accession no.
- 0001104659-23-033302
- Filed
- Mar 16, 2023
- Trade date
- Mar 14-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $254.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sulat James RCIK 0001229448 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Ordinary Shares | PPurchaseAcquired | +15,000 | $8.42 | +$126,300 | 67,553 | Direct | |
| Mar 15, 2023 | Ordinary Shares | PPurchaseAcquired | +15,000 | $8.54 | +$128,100 | 82,553 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.